Email:
Password:
  Remember
I forgot my password
Register new account
 
Xjenza Online Vol. 5 Iss. 2 - December 2017
Alcohol, Cannabinoids and Nicotine in Liver Pathophysiology

Authors: Manuela Radic, Francesca Rappa, Rosario Barone, Francesco Cappello, Giuseppe Crescimanno, Maurizio Casarrubea, Massimo Perucci, Antonella Marino Gammazza, Giuseppe Di Giovanni

Corresponding: Manuela Radic (manuela.radic@outlook.com)

Keywords: liver, alcohol, cannabinoids, nicotine

Doi: 10.7423/XJENZA.2017.2.05

Issue: Xjenza Online Vol. 5 Iss. 2 - December 2017

Abstract:
The liver can be affected by a wide range of therapeutic and environmental chemicals and here we want to provide a summary of the complex effects of alcohol, cannabinoids and nicotine on liver function. Alcohol is the most important agent that produces liver injury, manifesting as alcoholic fatty liver disease. In addition, it is one of the main etiologic agents for hepatocellular carcinoma development. Studies reviewed in this article regarding cannabinoids, show that 9-THC does not produce any harmful effects on the liver, while cannabidiol has hepatoprotective effects in ischemia/reperfusion and alcohol-induced liver injuries. The liver is negatively affected by nicotine exposure, but surprisingly nicotine was shown to have a positive effect on the liver in the diet-induced obese animal model, which should be confirmed by future research.